Campos MA - Search Results

1

Pharmacokinetic comparability of Prolastin®-C to Prolastin® in alpha₁-antitrypsin deficiency: a randomized study.

Stocks JM, Brantly ML, Wang-Smith L, Campos MA, Chapman KR, Kueppers F, Sandhaus RA, Strange C, Turino G. Stocks JM, et al. Among authors: campos ma. BMC Clin Pharmacol. 2010 Sep 30;10:13. doi: 10.1186/1472-6904-10-13. BMC Clin Pharmacol. 2010. PMID: 20920295 Free PMC article. Clinical Trial.

2

Trends in the diagnosis of symptomatic patients with alpha1-antitrypsin deficiency between 1968 and 2003.

Campos MA, Wanner A, Zhang G, Sandhaus RA. Campos MA, et al. Chest. 2005 Sep;128(3):1179-86. doi: 10.1378/chest.128.3.1179. Chest. 2005. PMID: 16162704

3

Influenza vaccination in subjects with alpha1-antitrypsin deficiency.

Campos MA, Alazemi S, Zhang G, Sandhaus RA, Wanner A. Campos MA, et al. Chest. 2008 Jan;133(1):49-55. doi: 10.1378/chest.07-1482. Epub 2007 Oct 1. Chest. 2008. PMID: 17908701

4

Clinical characteristics of subjects with symptoms of alpha1-antitrypsin deficiency older than 60 years.

Campos MA, Alazemi S, Zhang G, Salathe M, Wanner A, Sandhaus RA, Baier H. Campos MA, et al. Chest. 2009 Mar;135(3):600-608. doi: 10.1378/chest.08-1129. Epub 2008 Nov 18. Chest. 2009. PMID: 19017884

5

Effects of a disease management program in individuals with alpha-1 antitrypsin deficiency.

Campos MA, Alazemi S, Zhang G, Wanner A, Sandhaus RA. Campos MA, et al. COPD. 2009 Feb;6(1):31-40. doi: 10.1080/15412550802607410. COPD. 2009. PMID: 19229706

6

Exacerbations in subjects with alpha-1 antitrypsin deficiency receiving augmentation therapy.

Campos MA, Alazemi S, Zhang G, Wanner A, Salathe M, Baier H, Sandhaus RA. Campos MA, et al. Respir Med. 2009 Oct;103(10):1532-9. doi: 10.1016/j.rmed.2009.04.008. Epub 2009 May 21. Respir Med. 2009. PMID: 19464158 Free article.

7

The prevalence of alpha-1 antitrypsin deficiency among patients found to have airflow obstruction.

Rahaghi FF, Sandhaus RA, Brantly ML, Rouhani F, Campos MA, Strange C, Hogarth DK, Eden E, Stocks JM, Krowka MJ, Stoller JK. Rahaghi FF, et al. Among authors: campos ma. COPD. 2012 Aug;9(4):352-8. doi: 10.3109/15412555.2012.669433. Epub 2012 Apr 16. COPD. 2012. PMID: 22506682 Clinical Trial.

8

Safety and pharmacokinetics of 120 mg/kg versus 60 mg/kg weekly intravenous infusions of alpha-1 proteinase inhibitor in alpha-1 antitrypsin deficiency: a multicenter, randomized, double-blind, crossover study (SPARK).

Campos MA, Kueppers F, Stocks JM, Strange C, Chen J, Griffin R, Wang-Smith L, Brantly ML. Campos MA, et al. COPD. 2013 Dec;10(6):687-95. doi: 10.3109/15412555.2013.800852. Epub 2013 Jul 17. COPD. 2013. PMID: 23862647 Clinical Trial.

9

The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult.

Sandhaus RA, Turino G, Brantly ML, Campos M, Cross CE, Goodman K, Hogarth DK, Knight SL, Stocks JM, Stoller JK, Strange C, Teckman J. Sandhaus RA, et al. Chronic Obstr Pulm Dis. 2016 Jun 6;3(3):668-682. doi: 10.15326/jcopdf.3.3.2015.0182. Chronic Obstr Pulm Dis. 2016. PMID: 28848891 Free PMC article. Review.

10

Bioequivalence of a Liquid Formulation of Alpha₁-Proteinase Inhibitor Compared with Prolastin®-C (Lyophilized Alpha₁-PI) in Alpha₁-Antitrypsin Deficiency.

Barker AF, Campos MA, Brantly ML, Stocks JM, Sandhaus RA, Lee D, Steinmann K, Lin J, Sorrells S. Barker AF, et al. Among authors: campos ma. COPD. 2017 Dec;14(6):590-596. doi: 10.1080/15412555.2017.1376044. Epub 2017 Oct 6. COPD. 2017. PMID: 28985109 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

214 results

Search Page